REFERÊNCIAS
1. Cuchel M et al. Eur Heart J. 2023;44(25):2277-2291. 2. Raal FJ et al. Atherosclerosis. 2018;277:483-492. 3. McGowan MP et al. J Am Heart Assoc. 2019;8:e013225. 4.Tromp TR et al. Lancet. 2022;399:719-728. 5. France M et al. Atherosclerosis. 2016;255:128-139. 6. Family Heart Foundation. Diagnostic criteria for familial hypercholesterolemia.
7. Scientific Steering Committee on behalf of the Simon Broome Register Group.
BMJ. 1991;303(6807):893-896. 8. Williams RR, Hunt SC, Schumacher MC, et al. Am J Cardiol. 1993;72(2):171-176. 9. World Health Organization Human Genetics Programme. Familial Hypercholesterolaemia (FH): Report of a Second WHO Consultation.
World Health Organization; 1999. 10. McGowan MP, Hosseini Dehkordi SH, Moriarty PM, Duell PB. J Am Heart Assoc. 2019;8(24):e013225. 11. Tromp TR, Cuchel M. Curr Opin Lipidol. 2022;33(6):326-335. 12. Brunham LR, Ruel I, Aljenedil S, et al. Can
J Cardiol. 2018;34(12):1553-1563. 13. Cuchel M, Bruckert E, Ginsberg HN, et al. Eur Heart J. 2014;35(32):2146-2157. 14. Cuchel M, Lee PC, Hudgins LC, et al. J Am Heart Assoc. 2023;12(9):e029175.